J&J MedTech | Circulatory Restoration(@JJMT_CircRest):For International Audiences: The REDUCER I trial demonstrated #ShockwaveReducer's real-world impact on patients, with the following benefits at one year: ➡️ 66% decrease in total number of emergency department visits in the year after implantation ➡️ 71% ≥1 CCS improvement ➡️ 26% ≥2 CCS improvement Learn more: https://t.co/NrIjAUK5a3 Watch the study's lead investigator, Dr Stefan Verheye, discuss the 12-month results: https://t.co/kaEmRF4c6i Verheye S. et al. European Heart Journal. (2024) Vol 45 (Suppl 1) Safety info link in Bio. CAUTION: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada.

J&J MedTech | Circulatory Restoration@JJMT_CircRest

2026.06.29 09:00

For International Audiences: The REDUCER I trial demonstrated #ShockwaveReducer#'s real-world impact on patients, with the following benefits at one year: ➡️ 66% decrease in total number of emergency department visits in the year after implantation ➡️ 71% ≥1 CCS improvement ➡️ 26% ≥2 CCS improvement Learn more: Watch the study's lead investigator, Dr Stefan Verheye, discuss the 12-month results: Verheye S. et al. European Heart Journal. (2024) Vol 45 (Suppl 1) Safety info link in Bio. CAUTION: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada.